Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13:1648–1655
Article CAS PubMed Google Scholar
Barnholtz-Sloan JS, Sloan AE, Davis FG et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 22:2865–2872. https://doi.org/10.1200/JCO.2004.12.149
Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617
Wang N, Bertalan MS, Brastianos PK (2018) Leptomeningeal metastasis from systemic cancer: review and update on management. Cancer 124:21–35. https://doi.org/10.1002/cncr.30911
Schrijver WAME, Suijkerbuijk KPM, Van Gils CH et al (2018) Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis. J Natl Cancer Inst 110:568–580
Hulsbergen AFC, Claes A, Kavouridis VK et al (2020) Subtype switching in breast cancer brain metastases: a multicenter analysis. Neuro Oncol. https://doi.org/10.1093/neuonc/noaa013
Article PubMed PubMed Central Google Scholar
Cardoso F, Senkus E, Costa A et al (2018) 4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)†. Ann Oncol 29:1634–1657. https://doi.org/10.1093/annonc/mdy192
Article CAS PubMed Google Scholar
Lin NU, Borges V, Anders C et al (2020) Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial. J Clin Oncol 38:2610–2619. https://doi.org/10.1200/JCO.20.00775
Article CAS PubMed PubMed Central Google Scholar
Pérez-García JM, Batista MV, Cortez P et al (2022) Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial. Neuro Oncol. https://doi.org/10.1093/NEUONC/NOAC144
Article PubMed Central Google Scholar
Brastianos PK, Carter SL, Santagata S et al (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5:1164–1177. https://doi.org/10.1158/2159-8290.CD-15-0369
Article CAS PubMed PubMed Central Google Scholar
Turashvili G, Brogi E (2017) Tumor heterogeneity in breast cancer. Front Med 4:227. https://doi.org/10.3389/fmed.2017.00227
Tarin D (2008) Comparisons of metastases in different organs: biological and clinical implications. Clin Cancer Res 14:1923–1925
Morgan AJ, Giannoudis A, Palmieri C (2021) The genomic landscape of breast cancer brain metastases: a systematic review. Lancet Oncol. https://doi.org/10.1016/S1470-2045(20)30556-8
Bertucci F, Ng CKY, Patsouris A et al (2019) Genomic characterization of metastatic breast cancers. Nature 569:560–564. https://doi.org/10.1038/s41586-019-1056-z
Article CAS PubMed Google Scholar
Angus L, Smid M, Wilting SM et al (2019) The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies. Nat Genet 51:1450–1458. https://doi.org/10.1038/s41588-019-0507-7
Article CAS PubMed PubMed Central Google Scholar
Huang RSP, Haberberger J, Mcgregor K et al (2021) Clinicopathologic and genomic landscape of breast carcinoma brain metastases. Oncologist. https://doi.org/10.1002/onco.13855
Article PubMed PubMed Central Google Scholar
Giannoudis A, Sartori A, Eastoe L et al (2021) Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival. Breast Cancer Res Treat 190:241–253. https://doi.org/10.1007/S10549-021-06364-8
Article CAS PubMed PubMed Central Google Scholar
Da Silva L, Simpson PT, Smart CE et al (2010) HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res 12:R46. https://doi.org/10.1186/bcr2603
Article CAS PubMed PubMed Central Google Scholar
Wikman H, Lamszus K, Detels N et al (2012) Relevance of PTEN loss in brain metastasis formation in breast cancer patients. Breast Cancer Res 14:R49. https://doi.org/10.1186/BCR3150
Article CAS PubMed PubMed Central Google Scholar
Lee JY, Park K, Lim SH et al (2015) Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget 6:43731–43742. https://doi.org/10.18632/oncotarget.6192
Article PubMed PubMed Central Google Scholar
Bollig-Fischer A, Michelhaugh SK, Wijesinghe P et al (2015) Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics. Oncotarget 6:14614–14624. https://doi.org/10.18632/oncotarget.3786
Article PubMed PubMed Central Google Scholar
Schrijver WA, Selenica P, Lee JY et al (2018) Mutation profiling of key cancer genes in primary breast cancers and their distant metastases. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-17-2310
Article PubMed PubMed Central Google Scholar
De Mattos-Arruda L, Ng CKY, Piscuoglio S et al (2018) Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases. Oncotarget 9:20617–20630. https://doi.org/10.18632/oncotarget.25041
Article PubMed PubMed Central Google Scholar
Tyran M, Carbuccia N, Garnier S et al (2019) A comparison of DNA mutation and copy number profiles of primary breast cancers and paired brain metastases for identifying clinically relevant genetic alterations in brain metastases. Cancers (Basel). https://doi.org/10.3390/CANCERS11050665
Thulin A, Andersson C, Werner Rönnerman E et al (2021) Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors. Sci Rep 11:23548. https://doi.org/10.1038/s41598-021-02903-x
Article CAS PubMed PubMed Central Google Scholar
Gao R, Davis A, McDonald TO et al (2016) Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet 48:1119–1130. https://doi.org/10.1038/ng.3641
Article CAS PubMed PubMed Central Google Scholar
Magbanua MJM, Melisko M, Roy R et al (2013) Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res 73:7134–7143. https://doi.org/10.1158/0008-5472.CAN-13-2051
Article CAS PubMed Google Scholar
De M-A, Mayor R, Ng CKY et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. https://doi.org/10.1038/ncomms9839
Article PubMed PubMed Central Google Scholar
White MD, Klein RH, Shaw B et al (2021) Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.20040
Article PubMed PubMed Central Google Scholar
Fitzpatrick A, Iravani M, Mills A et al (2022) Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis. Clin Cancer Res 28:1180–1191. https://doi.org/10.1158/1078-0432.CCR-21-3017
Article CAS PubMed PubMed Central Google Scholar
Boire A, Brandsma D, Brastianos PK et al (2019) Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro Oncol 21:571–583. https://doi.org/10.1093/neuonc/noz012
Article CAS PubMed PubMed Central Google Scholar
Cheok SK, Narayan A, Arnal-Estape A et al (2021) Tumor DNA mutations from intraparenchymal brain metastases are detectable in CSF. JCO Precis Oncol. https://doi.org/10.1200/PO.20.00292
Article PubMed PubMed Central Google Scholar
Lee JH, Menzies AM, Carlino MS et al (2020) Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-3926
Article PubMed PubMed Central Google Scholar
Pentsova EI, Shah RH, Tang J et al (2016) Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol 34:2404–2415. https://doi.org/10.1200/JCO.2016.66.6487
Article CAS PubMed PubMed Central Google Scholar
Ma C, Yang X, Xing W et al (2020) Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Thoracic Cancer. https://doi.org/10.1111/1759-7714.13300
Article PubMed PubMed Central Google Scholar
von Baumgarten L, Kumbrink J, Jung A et al (2020) Therapeutic management of neuro-oncologic patients—potential relevance of CSF liquid biopsy. Theranostics 10:856–866. https://doi.org/10
留言 (0)